Zenith Drugs Soars: 39% Premium Over IPO on NSE SME
Introduction At Zenith Drugs, proud to announce that their stock lists at a remarkable 39% premium to the IPO price on the NSE SME platform. This significant milestone underscores commitment…
Introduction At Zenith Drugs, proud to announce that their stock lists at a remarkable 39% premium to the IPO price on the NSE SME platform. This significant milestone underscores commitment…